JPMorgan Chase & Co’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49
| Closed | -$67 | – | 6150 |
|
|
2025
Q1 | $67 | Sell |
49
-3
| -6% | -$4 | ﹤0.01% | 6052 |
|
|
2024
Q4 | $72 | Sell |
52
-2
| -4% | -$3 | ﹤0.01% | 6006 |
|
|
2024
Q3 | $58 | Sell |
54
-966
| -95% | -$1.04K | ﹤0.01% | 6017 |
|
|
2024
Q2 | $2.19K | Buy |
+1,020
| New | +$2.19K | ﹤0.01% | 5494 |
|
|
2023
Q2 | – | Sell |
-8,511
| Closed | -$84K | – | 5970 |
|
|
2023
Q1 | $84K | Buy |
8,511
+2,247
| +36% | +$22.2K | ﹤0.01% | 4717 |
|
|
2022
Q4 | $60K | Buy |
6,264
+3,640
| +139% | +$34.9K | ﹤0.01% | 4675 |
|
|
2022
Q3 | $46K | Buy |
2,624
+145
| +6% | +$2.54K | ﹤0.01% | 4725 |
|
|
2022
Q2 | $19K | Buy |
+2,479
| New | +$19K | ﹤0.01% | 5069 |
|